Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Sublease Agreement (Tables)

6 Months Ended

Jun. 30, 2015

The changes in the liability related to the sublease agreement for the six months ended June 30, 2015 were as follows (in thousands):

Balance at January 1, 2015	$	9,269
Accretion of deferred liability	304
Amortization of deferred liability	(1,682		)

Balance at June 30, 2015	$	7,891